Reports Q3 revenue $97.5M vs. $74.2M last year. “We have completed the financial restatement process and as of today, all amended filings are complete,” said Lorne Weil, executive chairman of Inspired. “For the first half of 2023, the net impact to Adjusted EBITDA from the restatement was effectively zero, with a $1 million decrease in previously reported results in Q1 offset by a $1 million increase in Q2. The impact to our Adjusted EBITDA for the full year 2022, was a decrease of $0.6 million, from $99.6 million to $99.0 million, or less than 1%. Adjusted EBITDA margin for the third quarter was 27%, but excluding Low Margin Gaming Hardware sales, the margin was 36%, compared to 37% in the prior year quarter.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on INSP:
- ‘Fundamentals Appear Positive’: KeyBanc Suggests 2 MedTech Stocks With up to ~40% Upside
- Inspire Medical’s New Regulation Risk – A Cause for Worry?
- Inspire Medical price target raised to $280 from $265 at Truist
- Inspire Medical price target raised to $270 from $240 at Lake Street
- Inspire Medical price target raised to $265 from $230 at BofA